• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program

    1/12/26 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email

    Model aims to extend access to FDA-approved obesity management medicines by leveraging the ubiquity of employer benefits

    CenterWell Pharmacy, a leader in specialty pharmacy and home delivery pharmacy, today announced that it will dispense Eli Lilly and Company (Lilly) obesity management medications as part of a new, employer-focused program administered by independent third-party administrators.

    CenterWell Pharmacy will serve as a dispensing pharmacy available to support eligible patients who participate in approved employer plan-sponsored obesity management carve-out programs. Third-party organizations will support employer groups and provide their health plan members with a flexible, transparent solution.

    "Employers continue to tell us they want to better support their employees' health but face real challenges in providing coverage for obesity management medicines," said Kevin Hern, Senior Vice President, Lilly Employer, Lilly USA. "We're excited to work with organizations that share our commitment to removing friction and providing flexible, transparent solutions for employers to help expand access to obesity management medicines for people who need them."

    The move underscores CenterWell Pharmacy's focus on building closer connections with employers to enhance health care access and affordability. As an approved dispensing pharmacy for select Lilly medicines, CenterWell Pharmacy will support prescription fulfillment and delivery, working closely with designated third-party organizations. CenterWell Pharmacy is a seven-time Specialty Pharmacy Patient Choice Award winner for best-in-class customer satisfaction and commitment to patient care.

    "We've already seen success in expanding access to obesity management medications through direct-to-patient distribution at more affordable price points," said Bethanie Stein, Pharm.D., President, Pharmacy at Humana, including CenterWell Pharmacy. "But there is an even larger opportunity for our health care system in making these medications available through forward-thinking employer-based programs. We at CenterWell Pharmacy are pleased to play an important role in standing up a more sustainable approach to distributing valuable weight loss medications."

    About CenterWell

    CenterWell is a leading health care services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high quality health care that is accessible, comprehensive, and, most of all, personalized. As the largest provider of senior-focused primary care, a leading provider of home health care, and a leading integrated home delivery, specialty, and retail pharmacy, CenterWell is focused on whole health and addressing the physical, emotional and social wellness of our patients.

    CenterWell is part of Humana Inc. (NYSE:HUM). Learn more about what we offer at CenterWell.com and CenterWellPharmacy.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260112005126/en/

    FOR MORE INFORMATION, CONTACT:

    Mark Mathis

    CenterWell Corporate Communications

    [email protected]

    Get the next $HUM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    12/5/2025$313.00Hold → Buy
    Jefferies
    10/14/2025$235.00Sell
    Goldman
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    More analyst ratings

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Humana from Outperform to Sector Perform and set a new price target of $189.00

    2/12/26 8:16:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Humana from Overweight to Equal Weight and set a new price target of $290.00

    1/7/26 8:56:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Shetty Sanjay K

    4 - HUMANA INC (0000049071) (Issuer)

    4/3/26 10:48:44 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Renaudin George Ii

    4 - HUMANA INC (0000049071) (Issuer)

    4/2/26 11:18:30 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Hilzinger Kurt J

    4 - HUMANA INC (0000049071) (Issuer)

    4/2/26 9:45:57 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    3/9/26 4:22:23 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form DEFR14A filed by Humana Inc.

    DEFR14A - HUMANA INC (0000049071) (Filer)

    3/6/26 5:31:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 424B5 filed by Humana Inc.

    424B5 - HUMANA INC (0000049071) (Filer)

    3/6/26 4:33:29 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana Inc. to Release First Quarter 2026 Results on April 29, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 1Q26 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BId1413c4c078343e28841e18c372f7b58.

    3/30/26 4:30:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Continuous Glucose Monitoring on the Rise Among Medicare Advantage Members with Type 2 Diabetes

    Study by Humana Healthcare Research and Yale School of Medicine researcher reveals significant increase in CGM usage, particularly among older adults with chronic health conditions. A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr. Joseph S. Ross of the Yale School of Medicine—reveals a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with type 2 diabetes from 2021 to 2023. The study also compared the demographic and clinical characteristics of members with type 2 diabetes who used CGMs with those who did not in 2023, finding that t

    3/12/26 9:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

    Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount (the "Junior Subordinated Notes Offering"). The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper pro

    3/9/26 5:00:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    Humana Inc. to Release First Quarter 2026 Results on April 29, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 1Q26 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BId1413c4c078343e28841e18c372f7b58.

    3/30/26 4:30:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 24, 2026 to stockholders of record as of the close of business on March 27, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large.

    2/19/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care